GBS Stock Price, News & Analysis (NYSE:GBS) $0.31 -0.02 (-5.98%) (As of 12/7/2023 ET) Add Compare Share Share Today's Range$0.31▼$0.3450-Day Range$0.21▼$1.1652-Week Range$0.36▼$2.89Volume913,969 shsAverage Volume955,325 shsMarket Capitalization$4.68 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media About GBS Stock (NYSE:GBS)GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Read More GBS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GBS Stock News HeadlinesDecember 7, 2023 | msn.com'I had no idea I was positive for deadly infection I could have passed my baby - until I got lucky moments before giving birth'December 1, 2023 | finance.yahoo.comBusiness of Design Week 2023 Officially Kicks Off at Freespace, West Kowloon Cultural DistrictDecember 8, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.November 30, 2023 | msn.comJoburg dad’s battle with Guillain-Barré syndrome and the extraordinary nurse who helped himNovember 29, 2023 | msn.comDeadly infection risk in newborns ‘could be higher than previously thought’November 29, 2023 | msn.comCommon bacteria carried by mothers poses deadly threat to newbornsNovember 23, 2023 | benzinga.comDaythree Achieves Remarkable Growth, with a Record RM66.3 Million in RevenueNovember 14, 2023 | yahoo.comGuillain-Barré Syndrome (GBS): Everything You Need to KnowDecember 8, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.November 13, 2023 | finance.yahoo.comGold Coast Motor Festival - A Spectacular Gathering of Local and International Car and Yacht Enthusiasts, Families, and Holiday-makersNovember 9, 2023 | msn.comGovernment allots R569m to propel SA’s BPO sectorNovember 8, 2023 | msn.comPatel says SA competitiveness has improved for Global Business ServicesNovember 6, 2023 | msn.comMiss Great Britain spotted at popular Glasgow restaurant leaving staff 'delighted'November 2, 2023 | finance.yahoo.comThe 5th Hong Kong Public Relations Awards Successfully HeldOctober 31, 2023 | msn.comUS households can now order four free Covid tests from the government – latest guidelinesOctober 30, 2023 | msn.com7 Reasons to Avoid an Apple 10.2-inch iPad TodayOctober 30, 2023 | mirror.co.ukUrgent warning after newborn dies as common condition 'turned son blue'October 26, 2023 | msn.comFlag Design Created By GBS Grad Celebrated At Exchange CeremonyOctober 25, 2023 | uk.style.yahoo.comGroup B Strep: Mum's plea for greater awareness of life-threatening infection after baby's meningitis battleOctober 24, 2023 | msn.comCan COVID Trigger an Autoimmune Disorder?October 21, 2023 | msn.comMum warns pregnant women after she almost lost her baby at Oldham hospitalOctober 19, 2023 | msn.comCovid-19 Might Trigger a Rare Paralyzing ConditionOctober 19, 2023 | msn.com'I wasn't told anything about life-threatening illness until my newborn nearly died from it'October 19, 2023 | msn.comRisk of Guillain-Barre syndrome 6 times higher after Covid infectionOctober 18, 2023 | msn.comGuillain-Barré syndrome risk greater after COVID-19, study indicatesOctober 18, 2023 | news.yahoo.comGuillain-Barré syndrome more common after COVID-19 infection, study suggestsOctober 18, 2023 | usnews.comGetting COVID Raises Odds for Guillain-Barre Syndrome, Vaccination Lowers RiskSee More Headlines Receive GBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/31/2022Today12/07/2023Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNYSE:GBS CUSIPN/A CIK1725430 Webwww.gbs.inc Phone646 828 8258FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,310,000.00 Net MarginsN/A Pretax Margin-1,907.09% Return on Equity-85.64% Return on Assets-54.42% Debt Debt-to-Equity RatioN/A Current Ratio2.33 Quick Ratio2.33 Sales & Book Value Annual Sales$440,000.00 Price / Sales10.65 Cash FlowN/A Price / Cash FlowN/A Book Value$0.44 per share Price / Book0.72Miscellaneous Outstanding Shares14,890,000Free Float14,850,000Market Cap$4.68 million OptionableNot Optionable Beta1.32 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Stephen Constantine Boyages M.D. (Age 64)MBBS, Ph.D., Interim CEO & Chairman Comp: $85.64kMr. Spiro Kevin Sakiris B.Bus (Age 60)C.A., CA, Dip Law, Chief Financial Officer Comp: $292.45kMr. Harry Simeonidis (Age 53)Pres of Asia Pacific Comp: $354.71kMs. Victoria Gavrilenko (Age 39)Operations Mang. Mr. Alex ArzenoVP of Investor RelationsKey CompetitorsQuoin PharmaceuticalsNASDAQ:QNRXTenon MedicalNASDAQ:TNONAvingerNASDAQ:AVGRBluejay DiagnosticsNASDAQ:BJDXAethlon MedicalNASDAQ:AEMDView All Competitors GBS Stock Analysis - Frequently Asked Questions How have GBS shares performed in 2023? GBS's stock was trading at $0.1999 on January 1st, 2023. Since then, GBS stock has increased by 57.4% and is now trading at $0.3146. View the best growth stocks for 2023 here. How were GBS's earnings last quarter? GBS Inc. (NYSE:GBS) posted its quarterly earnings data on Wednesday, August, 31st. The company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.04. How do I buy shares of GBS? Shares of GBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NYSE:GBS) was last updated on 12/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GBS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.